Switch to:
More From Other Websites
Business Highlights Nov 26 2014
5 Ways CEOs Handle Activist Investors Nov 25 2014
Today's Stocks Driving Success For The Drugs Industry Nov 25 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris Nov 25 2014
8:03 am Valeant Pharmaceuticals announces FDA approval of ONEXTON gel for the treatment of Acne... Nov 25 2014
JANA Partners adds a new position in Valeant Pharmaceuticals Nov 25 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris Nov 25 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris Nov 25 2014
Ariad Pharmaceuticals (ARIA) Jumps: Stock Gains 9.7% Nov 25 2014
JANA Partners opens a stake in Amgen Nov 24 2014
Notable option trades in equities Nov 24 2014
Activis, Allergan CEOs Discuss Details of Purchase Nov 24 2014
Highlights of activist fund JANA Partners’ 3Q 13F Nov 21 2014
What a week: Botox haze, merger Monday and The Tanned One Nov 21 2014
After losing out over Allergan, Valeant announces $2 billion buyback Nov 21 2014
Shire to Relocate Employees Under One Shire Program Nov 20 2014
Synergy Pharmaceuticals Drug Fares Well in Phase II Study Nov 20 2014
Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014
Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014
Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK